RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Pharmacy cost evaluation of risperidone, olanzapine, and quetiapine for the treatmetn of schizophrenia in acute care inpatient settings
Mladsi, D., Grogg, A., Irish, W., Lopez, R., Degen, K., Swann, A., & Nimsch, C. (2004). Pharmacy cost evaluation of risperidone, olanzapine, and quetiapine for the treatmetn of schizophrenia in acute care inpatient settings. Current Medical Research and Opinion, 20(12)(ISSN 0300-7995), 1883 - 1952.